Page last updated: 2024-08-22

pimozide and Neuromuscular Junction Diseases

pimozide has been researched along with Neuromuscular Junction Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aggad, D; Armstrong, GA; Ciura, S; Drapeau, P; Ichida, J; Julien, JP; Kabashi, E; Korngut, L; La Fontaine, A; Liao, M; Maios, C; Martinez, J; Parker, JA; Patten, SA; Petrillo, J; Rafuse, V; Robitaille, R; Tremblay, E; Wen, XY; Zinman, L	1

Trials

1 trial(s) available for pimozide and Neuromuscular Junction Diseases

Article	Year
Neuroleptics as therapeutic compounds stabilizing neuromuscular transmission in amyotrophic lateral sclerosis. JCI insight, 2017, 11-16, Volume: 2, Issue:22 Topics: Amyotrophic Lateral Sclerosis; Animals; Antipsychotic Agents; Caenorhabditis elegans; Calcium Channels; Calcium Channels, T-Type; Disease Models, Animal; DNA-Binding Proteins; Drug Evaluation, Preclinical; Drug Tolerance; Female; Mice; Neuromuscular Junction; Neuromuscular Junction Diseases; Pimozide; Zebrafish; Zebrafish Proteins	2017

Article

Year

Neuroleptics as therapeutic compounds stabilizing neuromuscular transmission in amyotrophic lateral sclerosis.

JCI insight, 2017, 11-16, Volume: 2, Issue:22

Topics: Amyotrophic Lateral Sclerosis; Animals; Antipsychotic Agents; Caenorhabditis elegans; Calcium Channels; Calcium Channels, T-Type; Disease Models, Animal; DNA-Binding Proteins; Drug Evaluation, Preclinical; Drug Tolerance; Female; Mice; Neuromuscular Junction; Neuromuscular Junction Diseases; Pimozide; Zebrafish; Zebrafish Proteins

2017